NYSEMKT: NSRX
Nasus Pharma Ltd Stock Forecast, Predictions & Price Target

Analyst price target for NSRX

Based on 1 analyst offering 12 month price targets for Nasus Pharma Ltd

Min Forecast
$22.00+196.9%
Avg Forecast
$22.00+196.9%
Max Forecast
$22.00+196.9%

Should I buy or sell NSRX stock?

Based on 1 analyst offering ratings for Nasus Pharma Ltd.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their NSRX stock forecasts and price targets.

NSRX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-09-29

1 of 1

NSRX vs General Drug Manufacturer Stocks

TickerPricePrice TargetUp/downsideConsensus
AZN$89.10N/AN/A
JNJ$195.93$199.71+1.93%Buy
MDCX$2.39$27.00+1,029.71%Strong Buy
GILD$125.02$133.20+6.54%Strong Buy
ABBV$232.36$252.08+8.49%Strong Buy

Nasus Pharma Stock Forecast FAQ

Is Nasus Pharma Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NYSEMKT: NSRX) stock is to Strong Buy NSRX stock.

Out of 1 analyst, 1 (100%) are recommending NSRX as a Strong Buy, 0 (0%) are recommending NSRX as a Buy, 0 (0%) are recommending NSRX as a Hold, 0 (0%) are recommending NSRX as a Sell, and 0 (0%) are recommending NSRX as a Strong Sell.

If you're new to stock investing, here's how to buy Nasus Pharma stock.

What is NSRX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year NSRX price target, the average NSRX price target is $22.00, with the highest NSRX stock price forecast at $22.00 and the lowest NSRX stock price forecast at $22.00.

The Wall Street analyst predicted that Nasus Pharma's share price could reach $22.00 by Sep 29, 2026. The average Nasus Pharma stock price prediction forecasts a potential upside of 196.9% from the current NSRX share price of $7.41.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.